Population
Patients with co-existing heart failure (systolic and diastolic dysfunction) and atrial fibrillation
Design
Review
Key result
Rate control remains the mainstay of treatment for atrial fibrillation in heart failure, while newer oral anticoagulants offer improved stroke prevention compared to traditional therapies.
Authors
Loading...
Supports rate control and NOACs for AF in HF; extends evidence synthesis while leaving optimal strategies open.
This review summarizes current management strategies for patients with coexisting heart failure and atrial fibrillation, highlighting rate control as the mainstay and the emerging role of newer oral anticoagulants.
Till et al. (2014) conducted a review in Atrial Fibrillation and Heart Failure. Rate control remains the mainstay of treatment for atrial fibrillation in heart failure, while newer oral anticoagulants offer improved stroke prevention compared to traditional therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: